| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |